Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950168-03-000859
Filing Date
2003-03-21
Accepted
2003-03-21 13:55:38
Documents
7
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K - VIROPHARMA, INC. d10k.htm 10-K 1462006
3 AGREEMENT BETWEEN ELLEN COOPER AND THE COMPANY dex1030.htm EX-10.30 56979
4 SETTLEMENT AGREEMENT dex1031.htm EX-10.31 35727
5 SCHEDULE OF RATIO OF EARNINGS TO FIXED CHARGES. dex121.htm EX-12.1 36333
6 LIST OF SUBSIDIARIES dex21.htm EX-21 1698
7 INDEPENDENT AUDITORS' CONSENT dex23.htm EX-23 2509
8 CERTIFICATION dex991.htm EX-99.1 4394
  Complete submission text file 0000950168-03-000859.txt   1601905
Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21699 | Film No.: 03612038
SIC: 2834 Pharmaceutical Preparations